Independent Validation of a Prognostic Genomic Signature (ColoPrint) for Patients With Stage II Colon Cancer

Author(s):
Maak, M.; Simon, I.; Nitsche, U.; Roepman, P.; Snel, M.; Glas, A.M.; Schuster, T.; Keller, G.; Zeestraten, E.; Goossens, I.; Janssen, K.P.; Friess, H.; Rosenberg, R.
Published
2013
Publication type
Article / Letter to editor
colon cancergene expressiongenomic signatureprognosisstage II
Date issued
2013-06-30
Language
English
Is part of
hdl
1887/108165
doi
10.1097/SLA.0b013e31827c1180